Making the Most of Oncology Patient Support Programs

A variety of real-world factors play into oncology outcomes that aren’t necessarily captured or accounted for in randomized controlled trials (RCTs). Drugmakers, care providers, and other stakeholders are attempting to collect data and address these gaps in care using patient support programs (PSPs), which allow for daily reporting of symptoms and treatment compliance.

According to , “Although cancer treatment is most commonly depicted within the clinical environment, in reality, most patients living with cancer will spend the majority of their time outside of a hospital. Having only brief and intermittent interactions with their doctors to discuss what they need to do to self-manage their health at home, these individuals and their loved ones face the prospect of navigating the complex landscape of cancer treatment on their own.”

To read more, click here.

(Source: PharmaPhorum, December 14^th, 2022)